Risk factors

The filing reflects ongoing capital raising needs, Nasdaq listing maintenance, and internal controls improvements. A key manufacturing vendor issue caused an FDA Complete Response Letter and a 12-month NDA delay. Insider ownership concentration decreased from 63% to 39%.

Company faces steep losses and negative cash flows while developing its mining and magnet manufacturing operations.

The VanEck Avalanche ETF is heavily exposed to the extreme volatility, protocol risks, and regulatory uncertainties of the Avalanche network and AVAX token.

Vine Hill Capital Investment Corp. II faces typical blank check company risks including finding a target and potential shareholder dilution. Management has conflicts of interest and operates without full-time commitment or guaranteed shareholder votes. Redemption rights and trust account constraints could delay or prevent closing an initial business combination.

Vor Biopharma expanded its portfolio by in-licensing telitacicept from RemeGen, creating new operational and regulatory dependencies on third-party trials in China.

The VanEck Solana ETF risk profile is dominated by extreme volatility in Solana (SOL) and its underlying network. Key operational threats include historical network outages, protocol bugs, consensus vulnerabilities, and concentration of ownership.

Xos highlights liquidity pressures, including the termination of its SEPA facility and reliance on an ATM stock offering.

Federal funding freezes and policy shifts threaten school budgets and demand for products.

This is an initial filing for Abony Acquisition Corp. I, a blank check company seeking an initial business combination. Key risks focus on target selection, management conflicts of interest, redemption rights, and regulatory compliance.

Concentrated exclusively in Bitcoin mining with Hut 8 managing operations.

Adagio Medical highlights ongoing clinical development risks, particularly for the FULCRUM-VT trial and vCLAS Cryoablation System.

Accumulated deficit increased to approximately $440.8 million as of December 31, 2025.